Newron Needs To Up Ante In Large-Scale Schizophrenia Studies
Executive Summary
Newron has reported positive Phase IIa data for schizophrenia drug evenamide but Phase III will be critical for the add-on therapy to demonstrate a more robust treatment effect to justify its use on top current treatments.